# Cambrex Karlskoga AB – FDA Inspection, May 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/cambrex-karlskoga-ab/0f6edfae-42d4-48d9-8549-6a5ea8de1c2b
Source feed: FDA_Inspections

> FDA inspection 1273764 of Cambrex Karlskoga AB, May 24, 2024. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273764
- Company Name: Cambrex Karlskoga AB
- Inspection Date: 2024-05-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1099984 - 2019-04-04](https://www.keypedia.com/records/fda_inspections/cambrex-karlskoga-ab/ca0a4baf-db05-4e42-9fe3-a8fea8c2e5b7)
- FDA Inspection 973499 - 2016-05-27
- FDA Inspection 870565 - 2014-03-21
- FDA Inspection 711913 - 2011-02-03

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/vickr-mra/15311fe2-330e-4820-a4d3-36a2ec70d9aa)

Company: https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
